Flow cytometry analysis of SPT-1 (Sézary Syndrome, a classified PTCL) and PT4 (unclassified PTCL) patient samples reveal strong and consistent CD3 expression in population subsets (data not shown). This evidence concerns the gene SPTLC1 and mature T-cell and NK-cell non-Hodgkin lymphoma.